Vaccination Concerns, Issues, and Motivators

Data Summary

Surveys are conducted online using Ipsos KnowledgePanel and the NORC AmeriSpeak probability-based panels. Data are based on responses from adults 18 years and older regarding COVID-19, flu, and RSV vaccination concerns, issues, and motivators. Estimates are updated every 2 months. Updates to concerns and issues data alternate publishing months with the motivators data.

Concerns and Issues

• For February 2025, the most commonly reported vaccination concern or issue among adults 18 years and older was "possible serious or unknown side effects" for COVID-19 vaccine (29.1%) and "not concerned about getting the flu" for flu vaccine (20.1%). This was consistent across demographic subgroups but varied by intent to get vaccinated.
• Among adults 60-74 years with high-risk condition(s) and adults 75 years and older, the most commonly reported concerns/issues about RSV vaccination were “do not know enough about RSV or the vaccine” (18.7%), “possible serious or unknown side effects” (18.5%), and "no provider recommendation" (17.7%). This was consistent across most demographic subgroups but varied by intent to get vaccinated.
• Many adults reported no concerns or issues about these vaccines (30.8% for COVID-19; 49.4% for flu; 47.6% for RSV).
  

Motivators

• For January 2025, the most commonly reported vaccination motivator among adults 18 years and older was "to protect myself" for COVID-19 (40.8%), flu (49.0%), and RSV (54.3%) vaccines. This was largely consistent across demographic subgroups but varied by intent to get vaccinated.
• Some adults reported nothing would motivate them to get these vaccines (28.1% for COVID-19; 25.0% for flu; 18.3% for RSV).

Download Data